# IRBESARTAN

NDC: 62332-043
Generic name: IRBESARTAN
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160701

FDA application: ANDA091236

## Active ingredients

- IRBESARTAN: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-043"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-043
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83f5d5c8-27c0-4208-a291-0c4aa55a1ff5
